Serial 18F-fluorodeoxyglucose positron emission tomography to assess the efficacy of infliximab in steroid refractory cardiac sarcoidosis
Year: 2025
Type: article
Study design: Observational Study
Abstract: Graphical abstract (only): Legend: Graphical abstract summarizing the findings of this observational study, which through serial 18F-FDG-PET/CT imaging, supports the use of infliximab in the management of refractory cardiac sarcoidosis. CMA - cardiac metabolic activity, EF - ejection fraction, 18F-FDG-PET/CT - fluorodeoxyglucose-positron emission tomography/computed tomography, LV - left ventricular, MRI - magnetic resonance imaging, SUV - standardized uptake value.
Source: Journal of Nuclear Cardiology
Authors: Louise E. Crowley, Ellen Jenkins, Akalanka Ranasinghe, Tamara Naneishvili, Mengshi Yuan, Khalid Hussain, Francisco Leyva-Leon, Anjali Crawshaw, William E. Moody
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,190
OpenAlex ID: W4411147845